Despite the numerous incentives, several challenges can impede innovation:
1. High Costs: The cost of developing new treatments is astronomical, often exceeding billions of dollars.
2. Regulatory Hurdles: Navigating the regulatory landscape can be time-consuming and complex, delaying the introduction of new therapies.
3. Scientific Uncertainty: The biological complexity of cancer means that many promising treatments fail in later stages of development.
4. Competitive Pressures: High competition in the pharmaceutical industry can sometimes lead to duplicated efforts rather than collaborative innovation.
